MSMiquel Àngel Schikora-Tamarit

Miquel Àngel Schikora-Tamarit

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Miquel Àngel Schikora-Tamarit has a total of 39 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Ancient whole genomes reveal regional selection during adaptation to Neolithic lifestyle in Western Eurasia

    by Miquel ÀNgel Schikora-Tamarit, Pablo Carrión, Simon Orozco-Arias, Aida Andrades Valtueña, Ana Ivanović, Christiana Lyn Scheib, Helja Kabral, Ivo Glynne Gut, Kristiina Tambets, Marta Gut, et al.

    The introduction of agriculture in Western Eurasia during the Mesolithic-Neolithic transition reshaped human lifestyle, demography and pathogen exposure. Yet, the associated selective pressures remain incompletely resolved because previous ancient DNA studies relied on targeted SNP panels and yielded non-overlapping results. Here, using high-coverage whole-genome data from 152 ancient individuals, including 12 newly sequenced genomes from the Iron Gates, we show that adaptation during this transition was geographically structured and involved selection of both Early Farmer and Hunter-Gatherer alleles. By combining scans of population differentiation, extended haplotype homozygosity, and adaptive admixture, we identify candidate loci under selection in ancestral and admixed populations. Extending the analysis beyond SNPs, we also detect differential copy-number variants, ancestry-associated shifts in transposable-element abundance, and an early Neolithic hepatitis B infection. Functional analyses including effects on gene expression suggested selection on immune, metabolic, reproductive, sensory, and behavioural processes. Taken together, our results reveal a broader and more regionally variable adaptive landscape than previously appreciated.

  • Open Access

    Reversible haploidisation and convergent genomic routes to antifungal resistance in the Candida parapsilosis species complex

    by Juan Carlos Nunez-Rodriguez, Vladislav Biriukov, Alvaro Redondo-Rio, Mrinalini Parmar, Miquel ÀNgel Schikora-Tamarit, Islam Ahaik, Valentina del Olmo, Toni Gabaldón

    Antifungal resistance is rising among non-albicans Candida, with outbreaks increasingly linked to drug-resistant Candida parapsilosis. Using large-scale experimental evolution under fluconazole and anidulafungin, coupled to phenotyping and genome sequencing, we define resistance strategies across C. parapsilosis, Candida metapsilosis and Candida orthopsilosis. Despite diverse genetic backgrounds, adaptation repeatedly converged on a shared genomic toolkit that combines protein-altering mutations in key regulators and drug targets (including MRR1 and FKS1) with copy-number changes, aneuploidy, as well as loss of heterozygosity driving resistance alleles to homozygosity. Strikingly, drug selection triggered recurrent but reversible haploidisation in C. orthopsilosis, revealing ploidy reduction as a transient, selectable survival strategy. Resistance, particularly after fluconazole selection, imposed fitness costs that promoted compensatory evolution and resistance loss after drug withdrawal. Together, antifungal adaptation in this complex affects convergent targets, while being plastic in its genomic routes, with implications for resistance surveillance and drug cycling therapies.


  • Open Access

    Dissection of genotype-phenotype relationships in Candida parapsilosis uncovers drivers of clinically-relevant traits

    by Miquel ÀNgel Schikora-Tamarit, Elena Lopez-Peralta, Alejandra Roldan, Cristina de Armentia, Alba Torres-Cano, Laura Álcazar-Fuoli, CAPAR Study Group, Oscar Zaragoza, Toni Gabaldón

    Hospital outbreaks caused by the fungal pathogen Candida parapsilosis are of growing concern due to their increased drug resistance and high mortality rates. However, the genetic bases of clinically-relevant traits in this species remain poorly explored. Here, we mapped genotype–phenotype relationships across 189 isolates from a multi-hospital Candida parapsilosis outbreak, for which we measured 61 diverse clinical phenotypes and generated complete genome sequences. As variation in previously-known genes explained little of the observed phenotypic diversity, we leveraged convergence genome-wide association studies and interpretable machine-learning models that predict phenotypes from genetic variants. These approaches identified candidate drivers of virulence and antifungal resistance, confirming expected mechanisms while uncovering novel ones. Predictive models were accurate for key traits, including azole resistance and clinical features of infected patients. Our results shed light on the genetic bases of clinically-relevant traits in a major fungal pathogen, and pave the way towards sequence-based diagnostics for improved patient outcomes.


  • Open Access

    Uncovering actionable trade-offs of antifungal resistance in a yeast pathogen

    by Juan Carlos Nunez-Rodriguez, Miquel ÀNgel Schikora-Tamarit, Toni Gabaldón

    The increasing prevalence of antifungal resistance represents a major clinical challenge. To explore potential new therapeutic avenues, we investigated fitness trade-offs associated with azole and echinocandin resistance in Nakaseomyces glabratus (syn. Candida glabrata ), a priority yeast pathogen showing growing incidence of drug and multidrug resistance. For this, we comprehensively phenotyped a large collection ( n = 77) of azole- and echinocandin-resistant strains to uncover resistance-associated stress sensitivity trade-offs. Our results show that increased stress sensitivity is a common trade-off of drug resistance in this species, with 98% of resistant strains exhibiting reduced fitness under at least one of six assayed stresses. Despite the diversity of genetic backgrounds and resistance mechanisms represented by our collection, we identified consistent trends in some resistance-associated vulnerabilities. Using multivariate modeling we uncovered complex genetic interactions underlying these trade-offs. As a proof of concept for therapeutic potential, we experimentally validated the inhibitory effects of targeting some fitness trade-offs. Cyclosporin A selectively inhibited anidulafungin-resistant strains, while NaCl effectively suppressed the emergence of fluconazole resistance. This study highlights the widespread occurrence of fitness costs associated with antifungal resistance and emphasizes their potential as a novel therapeutic strategy against this growing threat.


  • Open Access

    Recent gene selection and drug resistance underscore clinical adaptation across Candida species

    by Miquel Àngel Schikora-Tamarit, Toni Gabaldón

    Understanding how microbial pathogens adapt to treatments, humans and clinical environments is key to infer mechanisms of virulence, transmission and drug resistance. This may help improve therapies and diagnostics for infections with a poor prognosis, such as those caused by fungal pathogens, including Candida. Here we analysed genomic variants across approximately 2,000 isolates from six Candida species (C. glabrata, C. auris, C. albicans, C. tropicalis, C. parapsilosis and C. orthopsilosis) and identified genes under recent selection, suggesting a highly complex clinical adaptation. These involve species-specific and convergently affected adaptive mechanisms, such as adhesion. Using convergence-based genome-wide association studies we identified known drivers of drug resistance alongside potentially novel players. Finally, our analyses reveal an important role of structural variants and suggest an unexpected involvement of (para)sexual recombination in the spread of resistance. Our results provide insights on how opportunistic pathogens adapt to human-related environments and unearth candidate genes that deserve future attention.


  • Open Access

    PerSVade: personalized structural variant detection in any species of interest

    by Miquel Àngel Schikora-Tamarit, Toni Gabaldón

    Structural variants (SVs) underlie genomic variation but are often overlooked due to difficult detection from short reads. Most algorithms have been tested on humans, and it remains unclear how applicable they are in other organisms. To solve this, we develop perSVade (personalized structural variation detection), a sample-tailored pipeline that provides optimally called SVs and their inferred accuracy, as well as small and copy number variants. PerSVade increases SV calling accuracy on a benchmark of six eukaryotes. We find no universal set of optimal parameters, underscoring the need for sample-specific parameter optimization. PerSVade will facilitate SV detection and study across diverse organisms.


  • Open Access

    Shared evolutionary footprints suggest mitochondrial oxidative damage underlies multiple complex I losses in fungi

    by Miquel Àngel Schikora-Tamarit, Marina Marcet-Houben, Jozef Nosek, Toni Gabaldón

    Oxidative phosphorylation is among the most conserved mitochondrial pathways. However, one of the cornerstones of this pathway, the multi-protein complex NADH : ubiquinone oxidoreductase (complex I) has been lost multiple independent times in diverse eukaryotic lineages. The causes and consequences of these convergent losses remain poorly understood. Here, we used a comparative genomics approach to reconstruct evolutionary paths leading to complex I loss and infer possible evolutionary scenarios. By mining available mitochondrial and nuclear genomes, we identified eight independent events of mitochondrial complex I loss across eukaryotes, of which six occurred in fungal lineages. We focused on three recent loss events that affect closely related fungal species, and inferred genomic changes convergently associated with complex I loss. Based on these results, we predict novel complex I functional partners and relate the loss of complex I with the presence of increased mitochondrial antioxidants, higher fermentative capabilities, duplications of alternative dehydrogenases, loss of alternative oxidases and adaptation to antifungal compounds. To explain these findings, we hypothesize that a combination of previously acquired compensatory mechanisms and exposure to environmental triggers of oxidative stress (such as hypoxia and/or toxic chemicals) induced complex I loss in fungi.


  • Open Access

    Poor codon optimality as a signal to degrade transcripts with frameshifts

    by Miquel Àngel Schikora-Tamarit, Lucas B. Carey

    Living organisms are error-prone. Every second a single human cell produces over 100 transcripts with a substitution, frameshift or splicing error. Multiple mRNA quality control pathways exist to degrade these transcripts. Many of these pathways involve co-translational regulation of mRNA stability, such as nonsense mediated decay (NMD) and reduced stability of transcripts with suboptimal codon usage. Recent work has shown the existence of a genetic link between NMD and codon-usage mediated mRNA decay. Here we present new computational evidence that, because the codons following most frameshift errors are suboptimal, removal of mRNAs with such errors may be mediated by degradation of mRNAs with sub-optimal codons. Thus, most transcripts that contain frameshifts are subject to two modes of degradation. Author summary: Frameshifting errors are common and mRNA quality control pathways, such as nonsense-mediated decay (NMD), exist to degrade these aberrant transcripts. Recent work has shown the existence of a genetic link between NMD and codon-usage mediated mRNA decay. Here we present computational evidence that these pathways are synergic for removing frameshifts.

  • Poor codon optimality as a signal to degrade transcripts with frameshifts

    by Miquel Àngel Schikora-Tamarit, Lucas B. Carey

    Frameshifting errors are common and mRNA quality control pathways, such as nonsense-mediated decay (NMD), exist to degrade these aberrant transcripts. Recent work has shown the existence of a genetic link between NMD and codon-usage mediated mRNA decay. Here we present computational evidence that these pathways are synergic for removing frameshifts.


  • Open Access

    Promoter architecture determines cotranslational regulation of mRNA

    by Lorena Espinar, Miquel Àngel Schikora Tamarit, Júlia Domingo, Lucas B. Carey

    Information that regulates gene expression is encoded throughout each gene but if different regulatory regions can be understood in isolation, or if they interact, is unknown. Here we measure mRNA levels for 10,000 open reading frames (ORFs) transcribed from either an inducible or constitutive promoter. We find that the strength of cotranslational regulation on mRNA levels is determined by promoter architecture. By using a novel computational genetic screen of 6402 RNA-seq experiments, we identify the RNA helicase Dbp2 as the mechanism by which cotranslational regulation is reduced specifically for inducible promoters. Finally, we find that for constitutive genes, but not inducible genes, most of the information encoding regulation of mRNA levels in response to changes in growth rate is encoded in the ORF and not in the promoter. Thus, the ORF sequence is a major regulator of gene expression, and a nonlinear interaction between promoters and ORFs determines mRNA levels.